|
August 2007
ASCO to ask U.S. Medicare to revise rule on anemia drugs
August 30, 2007
WASHINGTON (Reuters) - U.S. cancer doctors on Thursday plan to ratchet up pressure on the federal Medicare agency to reverse new limits on use of anemia drugs made by Amgen Inc. and Johnson & Johnson.
Gabapentin improves opioid treatment of neuropathic cancer pain
August 30, 2007
NEW YORK (Reuters Health) - The combination of gabapentin and an opioid provides better relief of neuropathic pain in cancer patients than opioid monotherapy, results of a study published in the August issue of the Journal of Pain and Symptom Management indicate.
Hyperglycemia prevalent, associated with high mortality in AML
August 30, 2007
NEW YORK (Reuters Health) - Hyperglycemia increases the incidence of in-hospital death by nearly 40% in patients with acute myeloid leukemia (AML). The increase in mortality is seen even in patients with mild hyperglycemia, according to results of a retrospective study.
US FDA proposes sunscreen rule, cancer warning
August 23, 2007
WASHINGTON (Reuters) - U.S. regulators on Thursday proposed a new regulation governing the development and testing of retail sunscreens, including a new label warning consumers about the risk of skin cancer linked to sun exposure.
Racial variations found in breast cancer type and size
August 22, 2007
NEW YORK (Reuters Health) - Among women with a first breast cancer, black women are more likely to have larger tumors and to have more positive lymph nodes than white women, an analysis of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database shows.
Preservation of erectile function excellent after prostate brachytherapy
August 22, 2007
NEW YORK (Reuters Health) - Among men with good sexual function before treatment with low-dose brachytherapy for prostate cancer, erectile function is likely to remain good over the long term, according to a report in the August issue of BJU International.
Breast cancer vaccine looks safe, study shows
August 20, 2007
WASHINGTON (Reuters Life!) - A therapeutic vaccine designed for breast cancer appears to be safe in women with advanced disease and shows signs of actually slowing down tumor growth, U.S. researchers reported on Friday. Concurrent chemo-radiation offers best survival in advanced lung cancer
August 17, 2007
NEW YORK (Reuters Health) - Treatment of patients with locally advanced non-small cell lung cancer (NSCLC) with concomitant chemotherapy and radiation may be the most successful way to extend survival, according to researchers at the University of Amsterdam.
Doctors' recognition of approaching death in terminal patients seen unreliable
August 17, 2007
NEW YORK (Reuters Health) - Physician estimates of survival in terminally ill cancer patients are quite imprecise, especially for patients near death, according to findings published in the August 1st issue of the Journal of Clinical Oncology. Radiofrequency ablation effective for small, early stage renal tumors
August 16, 2007
NEW YORK (Reuters Health) - Radiofrequency ablation is a reasonable alternative to partial nephrectomy for the treatment of T1a renal tumors, according to findings published in the August issue of BJU International.
HPV vaccine has no therapeutic value against active HPV infection
August 14, 2007
NEW YORK (Reuters Health) - Human papillomavirus (HPV) vaccine does not accelerate clearance of HPV infections, investigators report in the Journal of the American Medical Association for August 13.
Vaccine works with chemotherapy in colorectal cancer
August 13, 2007
NEW YORK (Reuters Health) - Vaccination of colorectal cancer patients with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax, Oxford BioMedica), given along with chemotherapy, induces "potent" immune responses, UK researchers report in the August 1st issue of Clinical Cancer Research.
Sorafenib-interferon combo active against metastatic renal cell cancer
August 10, 2007
NEW YORK (Reuters Health) - The combination of sorafenib and interferon alfa-2b has substantial activity in patients with metastatic renal cell cancer, according to a phase II trial reported in the August 1st issue of the Journal of Clinical Oncology.
Intravesical therapies may reduce bladder cancer survival
August 10, 2007
NEW YORK (Reuters Health) - The increasing use of intravesical therapies for stage T1 bladder cancer has coincided with decreasing survival after cystectomy, according to New York-based researchers.
Zoledronic acid reduces bone damage in prostate cancer patients
August 9, 2007
NEW YORK (Reuters Health) - Zoledronic acid given every 3 months reduces bone density loss and bone turnover in men with hormone-sensitive prostate cancer, according to a new report.
Cannabinoid receptor inhibitors may prevent doxorubicin toxicity
August 9, 2007
NW YORK (Reuters Health) - The severe cardiotoxicity that can limit the use of the antitumor agent, doxorubicin, appears to be minimized with antagonists to the cannabinoid-1 (CB-1) receptor, according to the results of in vivo and in vitro research.
Good outcomes with conservative management of stage IB1 cervical cancer
August 9, 2007
NEW YORK (Reuters Health) - Conservative surgical management of small-volume stage IB1 cervical cancer provides excellent outcomes, according to findings published in the August issue of BJOG: An International Journal of Obstetrics and Gynaecology.
Left-sided breast cancer radiation boosts coronary risk
August 9, 2007
NEW YORK (Reuters Health) - Early-stage breast cancer patients treated with left-sided radiation as a component of breast conservation have an increased risk of late, radiation-associated coronary damage, according to researchers.
MRI may aid diagnosis of ductal carcinoma in situ
August 9, 2007
NEW YORK (Reuters Health) - The findings from a new study support a role for MRI in detecting ductal carcinoma in situ (DCIS), particularly disease with a high nuclear grade.
Women's cancer care often ignores sexual issues
August 8, 2007
NEW YORK (Reuters Health) - Long-term survivors of vaginal and cervical cancer are as likely as other women to be sexually active, but they have a lot more sex-related problems and these are often not addressed by their doctors, researchers report.
Avastin improves survival in metastatic cancer, but ups risk of arterial embolism
August 7, 2007
NEW YORK (Reuters Health) - When added to conventional chemotherapy for treatment of metastatic cancer, bevacizumab (Avastin; Genentech, Inc.) significantly prolongs survival. But results of a meta-analysis suggest that bevacizumab slightly increases the risk of arterial thromboembolism.
Surveillance mammography reduces mortality in older breast cancer survivors
August 3, 2007
NEW YORK (Reuters Health) - Mammographic surveillance is associated with a reduction in breast cancer mortality among older women who have survived the malignancy once, according to a report in the Journal of Clinical Oncology for July 20.
Laparoscopic-assisted surgery provides good long-term outcomes in colon cancer
August 2, 2007
NEW YORK (Reuters Health) - As late as 3 years after surgery, the results of laparoscopic-assisted resection of colorectal cancer are as good as results with open surgery, according to a report in the July 20th issue of the Journal of Clinical Oncology.
Minimally invasive therapy destroys kidney cancer
August 2, 2007
NEW YORK (Reuters Health) - Patients with kidney cancer who are poor candidates for surgery can be treated using a less invasive alternative, according to a study conducted at Wake Forest University in Winston-Salem, North Carolina.
Chemo added to radiation improves survival in elderly lung cancer patients
August 1, 2007
NEW YORK (Reuters Health) - Patients aged more than 65 years with non-small cell lung cancer (NSCLC) live longer when treated with combined-modality therapy, but at the cost of greater toxicity, researchers report.
|
